Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
2	2	Search

2026	Sequential anlotinib and camrelizumab combination therapy achieves exceptional survival in multi-driver mutated, TMB-low/PD-L1-low/MSS pulmonary sarcomatoid carcinoma: case report and literature review Frontiers in Immunology Jun Zhu, Ai Zhu, Gang Li, Lidong Liu, Ziran Gao, Jiayun Liu, Yunfei Ye, Xunzhi Zhu, Yi Li, Hong Chen, Meijin Huang
2025	Cancer histone mutations impact protein binding and DNA repair with possible links to genomic instability Nucleic Acids Research Daniel Espiritu, Yiru Sheng, Yunhui Peng, Daria Ostroverkhova, Shuxiang Li, David Landsman, Maria J Aristizabal, Anna R Panchenko